The evolution of systolic blood pressure as a strong predictor of cardiovascular risk and the effectiveness of fixed-dose ARB/CCB combinations in lowering levels of this preferential target

References

• AdlerAIStrattonIMNeilHA2000Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational studyBMJ321412910938049
   PubMed Web of Science ®Google Scholar
• BangaloreSKamalakkannanGParkarS2007Fixed-dose combinations improve medication compliance: a meta-analysisAm J Med120713917679131
   PubMed Web of Science ®Google Scholar
• BenetosAThomasFBeanKE2003Why cardiovascular mortality is higher in treated hypertensives versus subjects of the same age, in the general populationJ Hypertens2116354012923394
   PubMed Web of Science ®Google Scholar
• BenetosAThomasFSafarME2000Should diastolic and systolic blood pressure be considered for cardiovascular risk evaluation: a study in middle-aged men and womenJ Am Coll Cardiol37163811153732
   PubMed Web of Science ®Google Scholar
• BlackHRElliottWJNeatonJD2001Baseline characteristics and early blood pressure control in the CONVINCE TrialHypertension37121811208750
   PubMed Web of Science ®Google Scholar
• BlackHR2004The paradigm has shifted to systolic blood pressureJ Hum Hypertens18S3S715592571
   PubMed Web of Science ®Google Scholar
• ChobanianAVBakrisGLBlackHR2003The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 reportJAMA28925607212748199
   PubMed Web of Science ®Google Scholar
• ChrysantSGMelinoMKarkiS2008The Combination of Olmesartan Medoxomil and Amlodipine Besylate in Controlling High Blood Pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety studyClin Ther3058760418498909
   PubMed Web of Science ®Google Scholar
• CushmanWCFordCECutlerJA2002Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)J Clin Hypertens (Greenwich)439340412461301
   PubMedGoogle Scholar
• ElliottWJ2002Is fixed combination therapy appropriate for initial hypertension treatment?Curr Hypertens Rep42788512117454
   PubMed Web of Science ®Google Scholar
• FramptonJECurranMP2007Aliskiren: a review of its use in the management of hypertensionDrugs6717679217683174
   PubMed Web of Science ®Google Scholar
• FranklinSSJacobsMJWongND2001Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives: analysis based on National Health and Nutrition Examination Survey (NHANES) IIIHypertension378697411244010
   PubMed Web of Science ®Google Scholar
• FranklinSS2000Is there a preferred antihypertensive therapy for isolated systolic hypertension and reduced arterial compliance?Curr Hypertens Rep2253910981158
   PubMedGoogle Scholar
• FungVHuangJBrandR2007Hypertension treatment in a medicare population: adherence and systolic blood pressure controlClin Ther299728417697916
   PubMed Web of Science ®Google Scholar
• HanonOHaulonSLenoirH2005Relationship between arterial stiffness and cognitive function in elderly subjects with complaints of memory lossStroke362193716151027
   PubMed Web of Science ®Google Scholar
• HanonOPequignotRSeuxML2006Relationship between antihypertensive drug therapy and cognitive function in elderly hypertensive patients with memory complaintsJ Hypertens242101716957572
   PubMed Web of Science ®Google Scholar
• HanssonLLloydAAndersonPKoppZ2002Excess morbidity and cost of failure to achieve targets for blood pressure control in EuropeBlood Press11354511926349
   PubMed Web of Science ®Google Scholar
• HymanDJPavlikVN2001Characteristics of patients with uncontrolled hypertension in the United StatesN Engl J Med3454798611519501
   PubMed Web of Science ®Google Scholar
• InoueROhkuboTKikuyaM2007Stroke risk in systolic and combined systolic and diastolic hypertension determined using ambulatory blood pressure. The Ohasama studyAm J Hypertens2011253117903698
   PubMed Web of Science ®Google Scholar
• JamersonKABakrisGLDahlöfB2008Avoiding cardiovascular events through combination therapy in patients living with systolic hypertension [abstract]57th Annual Scientific Session of the American College of Cardiology29 Mar 2008abstr. 407–2.
   Google Scholar
• JamersonKANwoseOJean-LouisL2004Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertensionAm J Hypertens1749550115177521
   PubMed Web of Science ®Google Scholar
• Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure1997The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressureArch Intern Med1572413469385294
   PubMed Web of Science ®Google Scholar
• KalacheAKellerI2000The greying world: a challenge for the twenty-first centurySci Prog83335410800373
   PubMedGoogle Scholar
• KannelWBGordonTSchwartzMJ1971Systolic versus diastolic blood pressure and risk of coronary heart disease. The Framingham studyAm J Cardiol27335465572576
   PubMed Web of Science ®Google Scholar
• LacourcièreYPoirierLHebertD2005Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trialClin Ther2710132116154480
   PubMed Web of Science ®Google Scholar
• LewingtonSClarkeRQizilbashNProspective Studies Collaboration2002Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studiesLancet36019031312493255
   PubMed Web of Science ®Google Scholar
• LindholmLHCarlbergBSamuelssonO2005Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysisLancet36615455316257341
   PubMed Web of Science ®Google Scholar
• LiuLWangJGGongL1998Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative GroupJ Hypertens16182399869017
   PubMed Web of Science ®Google Scholar
• Lloyd-JonesDMEvansJCLarsonMG2000Differential control of systolic and diastolic blood pressure: factors associated with lack of blood pressure control in the communityHypertension36594911040241
   PubMed Web of Science ®Google Scholar
• MacMahonSPetoRCutlerJ1990Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution biasLancet335765741969518
   PubMed Web of Science ®Google Scholar
• ManciaGDe BackerGDominiczakA2007Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)Eur Heart J28146253617562668
   PubMed Web of Science ®Google Scholar
• ManciaGGrassiG2002Systolic and diastolic blood pressure control in antihypertensive drug trialsJ Hypertens201461412172300
   PubMed Web of Science ®Google Scholar
• MesserliFHManciaGContiCR2006Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous?Ann Intern Med1448849316785477
   PubMed Web of Science ®Google Scholar
• MouradJJNguyenVLopez-SubletM2007Blood pressure normalization in a large population of hypertensive patients treated with perindopril/indapamide combination: results of the OPTIMAX trialVasc Health Risk Manag31738017583188
   PubMedGoogle Scholar
• National Collaborating Centre for Chronic Conditions2006Hypertension: management of hypertension in adults in primary care: partial updateLondonRoyal College of Physicians
   Google Scholar
• NeutelJMFranklinSSOparilS2006Efficacy and safety of irbesartan/HCTZ combination therapy as initial treatment for rapid control of severe hypertensionJ Clin Hypertens88507
   PubMedGoogle Scholar
• OsherESternN2008Diastolic pressure in type 2 diabetes: can target systolic pressure be reached without ‘diastolic hypotension’?Diabetes Care31S2495418227493
   PubMed Web of Science ®Google Scholar
• OsterbergLBlaschkeT2005Adherence to medicationN Engl J Med3534879716079372
   PubMed Web of Science ®Google Scholar
• PadwalRStrausSEMcAlisterFA2001Evidence based management of hypertension. Cardiovascular risk factors and their effects on the decision to treat hypertension: evidence based reviewBMJ3229778011312234
   PubMed Web of Science ®Google Scholar
• PatelAMacMahonSChalmersJ2007Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trialLancet3708294017765963
   PubMed Web of Science ®Google Scholar
• PayneKAEsmonde-WhiteS2000Observational studies of antihypertensive medication use and compliance: is drug choice a factor in treatment adherence?Curr Hypertens Rep25152411062596
   PubMedGoogle Scholar
• PeraltaCAShlipakMGWassel-FyrC2007Association of antihypertensive therapy and diastolic hypotension in chronic kidney diseaseHypertension504748017664397
   PubMed Web of Science ®Google Scholar
• PhilippTSmithTRGlazerR2007Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertensionClin Ther295638017617280
   PubMed Web of Science ®Google Scholar
• PohlMABlumenthalSCordonnierDJ2005Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the irbesartan diabetic nephropathy trial: clinical implications and limitationsJ Am Soc Nephrol1630273716120823
   PubMed Web of Science ®Google Scholar
• PoldermansDGlazesRKargiannisS2007Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertensionClin Ther292798917472820
   PubMed Web of Science ®Google Scholar
• ProtogerouADSafarMEIariaP2007Diastolic blood pressure and mortality in the elderly with cardiovascular diseaseHypertension501728017515449
   PubMed Web of Science ®Google Scholar
• Roca-CusachsASchmiederRETriposkiadisF2008Efficacy of manidipine/delapril versus losartan/hydrochlorothiazide fixed combinations in patients with hypertension and diabetesJ Hypertens26813818327093
   PubMed Web of Science ®Google Scholar
• RuilopeLMMalaccoEKhderY2005Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST studyClin Ther275788715978306
   PubMed Web of Science ®Google Scholar
• SHEP Cooperative Research Group1991Prevention of stroke by anti-hypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP)JAMA2653255642046107
   PubMed Web of Science ®Google Scholar
• ShlyakhtoE2007Observational Study on Cognitive function And systolic blood pressure Reduction (OSCAR): preliminary analysis of 6-month data from >10,000 patients and review of the literatureCurr Med Res Opin23Suppl 5S13818093409
   PubMedGoogle Scholar
• SingerGMIzharMBlackHR2002Goal-oriented hypertension management: translating clinical trials to practiceHypertension40464912364348
   PubMed Web of Science ®Google Scholar
• StaessenJAFagardRThijsL1997Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial InvestigatorsLancet350757649297994
   PubMed Web of Science ®Google Scholar
• StaessenJAGasowskiJWangJG2000Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trialsLancet3558657210752701
   PubMed Web of Science ®Google Scholar
• StaessenJAWangJGThijsL2001Cardiovascular protection and blood pressure reduction: a meta-analysisLancet35813051511684211
   PubMed Web of Science ®Google Scholar
• StaessenJAWangJGThijsL2003Cardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1 March 2003J Hypertens2110557612777939
   PubMed Web of Science ®Google Scholar
• StamlerJStamlerRNeatonJD1993Blood pressure, systolic and diastolic, and cardiovascular risks. US population dataArch Intern Med1535986158439223
   PubMed Web of Science ®Google Scholar
• SteckelingsUMStoppelhaarMSharmaAM2004HYDRA: possible determinants of unsatisfactory hypertension control in German primary care patientsBlood Press1380815182110
   PubMed Web of Science ®Google Scholar
• SwalesJD1999Current clinical practice in hypertension: the EISBERG (Evaluation and Interventions for Systolic Blood pressure Elevation-Regional and Global) projectAm Heart J138231710467218
   PubMed Web of Science ®Google Scholar
• ThijsLDen HondENawrotT2004Prevalence, pathophysiology and treatment of isolated systolic hypertension in the elderlyExpert Rev Cardiovasc Ther2761915350177
   PubMedGoogle Scholar
• TurnbullFBlood Pressure Lowering Treatment Trialists’ Collaboration2003Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trialsLancet36215273514615107
   PubMed Web of Science ®Google Scholar
• WaeberBMouradJJ2006Targeting systolic blood pressure: the key to controlling combined systolic/diastolic hypertensionAm J Hypertens19985616942945
   PubMed Web of Science ®Google Scholar
• WaeberB2003Trials in isolated systolic hypertension: an updateCurr Cardiol Rep54273414558982
   PubMedGoogle Scholar
• WallaceSMYasminMcEnieryCM2007Isolated systolic hypertension is characterized by increased aortic stiffness and endothelial dysfunctionHypertension502283317502493
   PubMed Web of Science ®Google Scholar
• WhitworthJAWorld Health Organization, International Society of Hypertension Writing Group2003World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertensionJ Hypertens219839214597836
   PubMedGoogle Scholar
• WongNDLopezVAL’ItalienG2007Inadequate control of hypertension in US adults with cardiovascular disease comorbidities in 2003–2004Arch Intern Med1672431618071164
   PubMed Web of Science ®Google Scholar
• ZiemanSJMelenovskyVClattenburgL2007Advanced glycation endproduct crosslink breaker (alagebrium) improves endothelial function in patients with isolated systolic hypertensionJ Hypertens255778317278974
   PubMed Web of Science ®Google Scholar